“Is UiPath Stock an Undervalued Stock to Buy Right Now in September? | PATH Stock Analysis”
PATH is an attractive buy; DCF fair value $18.40 vs price $14 implies 31% upside as market overestimates AI risk to its growing business.
UiPath is one of these companies that artificial intelligence was supposed to kill. Instead, the company reported revenue increasing 13% year-over-year in its most recently completed quarter, and the CEO is pleased with their second quarter results.
Does this make UiPath stock an interesting buying opportunity? So, rather than killing its business, the CEO and founder Daniel Dines said, "AI is expanding what enterprises can automate, while increasing the need for orchestration, governance, and exactness that deterministic automation provides.
Their ability to bring AI agents, robot systems, and people together to execute end-to-end process positions UiPath at the center of this opportunity."